List of Tables
Table 1. Global Psoriasis Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tumor Necrosis Factor Inhibitor
Table 3. Key Players of Interleukin Inhibitors
Table 4. Key Players of Others
Table 5. Global Psoriasis Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Psoriasis Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Psoriasis Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Psoriasis Drugs Market Share by Regions (2016-2021)
Table 9. Global Psoriasis Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Psoriasis Drugs Market Share by Regions (2022-2027)
Table 11. Psoriasis Drugs Market Trends
Table 12. Psoriasis Drugs Market Drivers
Table 13. Psoriasis Drugs Market Challenges
Table 14. Psoriasis Drugs Market Restraints
Table 15. Global Psoriasis Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Psoriasis Drugs Market Share by Players (2016-2021)
Table 17. Global Top Psoriasis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriasis Drugs as of 2020)
Table 18. Ranking of Global Top Psoriasis Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Psoriasis Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Psoriasis Drugs Product Solution and Service
Table 22. Date of Enter into Psoriasis Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Psoriasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Psoriasis Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Psoriasis Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Psoriasis Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Psoriasis Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Psoriasis Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Psoriasis Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Psoriasis Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Psoriasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Psoriasis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Psoriasis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Psoriasis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Psoriasis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Psoriasis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Psoriasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Psoriasis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Psoriasis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Psoriasis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Psoriasis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Psoriasis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Psoriasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Psoriasis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Psoriasis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Psoriasis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Psoriasis Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Psoriasis Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Psoriasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Psoriasis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Psoriasis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Psoriasis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Psoriasis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Psoriasis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Psoriasis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Psoriasis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Psoriasis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Psoriasis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Psoriasis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Psoriasis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. AbbVie Company Details
Table 63. AbbVie Business Overview
Table 64. AbbVie Psoriasis Drugs Product
Table 65. AbbVie Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 66. AbbVie Recent Development
Table 67. Amgen Company Details
Table 68. Amgen Business Overview
Table 69. Amgen Psoriasis Drugs Product
Table 70. Amgen Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 71. Amgen Recent Development
Table 72. Johnson & Johnson Company Details
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Psoriasis Drugs Product
Table 75. Johnson & Johnson Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 76. Johnson & Johnson Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Psoriasis Drugs Product
Table 80. Novartis Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Eli Lilly & Company Company Details
Table 83. Eli Lilly & Company Business Overview
Table 84. Eli Lilly & Company Psoriasis Drugs Product
Table 85. Eli Lilly & Company Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 86. Eli Lilly & Company Recent Development
Table 87. AstraZeneca Company Details
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Psoriasis Drugs Product
Table 90. AstraZeneca Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 91. AstraZeneca Recent Development
Table 92. Celgene Corporation Company Details
Table 93. Celgene Corporation Business Overview
Table 94. Celgene Corporation Psoriasis Drugs Product
Table 95. Celgene Corporation Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 96. Celgene Corporation Recent Development
Table 97. UCB Company Details
Table 98. UCB Business Overview
Table 99. UCB Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 100. UCB Recent Development
Table 101. Merck Company Details
Table 102. Merck Business Overview
Table 103. Merck Psoriasis Drugs Product
Table 104. Merck Revenue in Psoriasis Drugs Business (2016-2021) & (US$ Million)
Table 105. Merck Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psoriasis Drugs Market Share by Type: 2020 VS 2027
Figure 2. Tumor Necrosis Factor Inhibitor Features
Figure 3. Interleukin Inhibitors Features
Figure 4. Others Features
Figure 5. Global Psoriasis Drugs Market Share by Application: 2020 VS 2027
Figure 6. Topicals Case Studies
Figure 7. Systemic Case Studies
Figure 8. Biologics Case Studies
Figure 9. Psoriasis Drugs Report Years Considered
Figure 10. Global Psoriasis Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Psoriasis Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Psoriasis Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Psoriasis Drugs Market Share by Regions (2022-2027)
Figure 14. Global Psoriasis Drugs Market Share by Players in 2020
Figure 15. Global Top Psoriasis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriasis Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Psoriasis Drugs Revenue in 2020
Figure 17. Global Psoriasis Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Psoriasis Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Psoriasis Drugs Market Share by Type (2016-2027)
Figure 21. North America Psoriasis Drugs Market Share by Application (2016-2027)
Figure 22. North America Psoriasis Drugs Market Share by Country (2016-2027)
Figure 23. United States Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Psoriasis Drugs Market Share by Type (2016-2027)
Figure 27. Europe Psoriasis Drugs Market Share by Application (2016-2027)
Figure 28. Europe Psoriasis Drugs Market Share by Country (2016-2027)
Figure 29. Germany Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Psoriasis Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Psoriasis Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Psoriasis Drugs Market Share by Region (2016-2027)
Figure 39. China Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Psoriasis Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Psoriasis Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Psoriasis Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Psoriasis Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Psoriasis Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Psoriasis Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Psoriasis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AbbVie Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 59. Amgen Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 61. Novartis Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 62. Eli Lilly & Company Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 64. Celgene Corporation Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 65. UCB Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 66. Merck Revenue Growth Rate in Psoriasis Drugs Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

LIST OF FIGURE